Category Archives: Business News
May 2012 – Steven G. Anderson, president and chief executive officer of CryoLife, said, “The acquisition of Hemosphere significantly advances our strategic initiative to reposition CryoLife’s product portfolio with higher growth, higher margin medical devices for cardiac and vascular surgery. … Continue reading
March 2012 — Hemosphere sold the 5000th HeRO Graft marking a significant milestone in the company’s history. “With the continued focus on infection reduction in the hospital and clinical setting, … HeRO is quickly becoming the standard of care for … Continue reading
March 2012 — The NKF recently published a clinical bulletin entitled; “A Clinical Update on an Alternative Vascular Access for the Cathter-Dependent Hemodialysis Patient.” This bulletin was written, reviewed and edited in peer review fashion by a panel of NKF-chosen … Continue reading
After a year with Hemosphere as Controller and Director of Operations, David Krenn has been promoted to Vice President of Finance to support company growth and infrastructure.
In conjunction with the Controversies in Dialysis Access (CiDA) Conference and the Renal Physicians Association (RPA) Annual Meeting, Hemosphere sponsored an Inter-Disciplinary Team (IDT) Forum last fall 2011 and mid-March 2012. The IDT Forum is a program designed to share … Continue reading
November 2011 — The Premier healthcare alliance announced new agreements for dialysis products and accessories have been awarded to AngioDynamics, B. Braun Medical, Covidien, Hemosphere, and Medical Components. Effective Nov. 1, the agreements are available to acute care and continuum … Continue reading
September 2011 — “CE Mark approval of the HeRO Graft allows us to build upon the already successful commercialization of the HeRO Graft in the U.S.,” said Patrick Wethington, Hemosphere President and CEO. “Receiving EC and ISO 13485 Certification demonstrates … Continue reading
June 2011 — The HeRO Graft was chosen from over 140 applicants to be part of Premier’s national program recognizing advances in healthcare and featured at the Innovations Celebration along with 17 other healthcare companies. HeRO Graft was selected by … Continue reading
May 2011 — Surgeons from Duke University, a HeRO Center of Excellence, presented case experience with the HeRO graft in Istanbul, Turkey at the 7th Congress of Vascular Access Society. The full presentation is available here.
Jim Bullock, President and CEO of Atritech, Inc., joined the Board of Directors at Hemosphere in March 2011. Atritech was recently acquired by Boston Scientific. Mr. Bullock brings over 30 years of professional experience in the medical industry. He was … Continue reading
Shawn Gage, MD, a PA-C of Vascular Surgery at Duke University Medical Center, received an invitation to present the abstract titled, “Central venous recanalization and subsequent implantation of the Hemodialysis Reliable Outflow (HeRO®) device in catheter dependent patients” at the … Continue reading
An abstract entitled “Early experience with percutaneous interventions on failing HeRO arteriovenous grafts“ was presented at the Society of Interventional Radiology (SIR) in Chicago, IL, March 30, 2011, by Duke University Medical Center. 50 HeRO graft patients were studied and … Continue reading
We are pleased and honored to be selected amongst a host of emerging medical device companies to receive the Therapeutic Discovery Project Grant. Over 4,600 companies from 47 states applied for the Treasury Department grant to support innovation in biotechnology and medical … Continue reading
November 2010 — Two posters were presented at the American Society of Nephrology’s Renal Week in Denver, CO, November 16-21, 2010. The largest post-market dataset available with 6 and 12 month followup was presented by Shawn Gage, Duke University. The … Continue reading
October 2010 — Controversies in Dialysis Access (CiDA) was held in San Francisco with over 500 attendees. Multiple access surgeons shared their personal experience with colleagues from the podium, in case study reviews, and poster presentations.
June 2010 – Patrick Wethington has joined the company as its new CEO, effective immediately. Wethington brings 18 years of medical device experience and succeeds Doris Engibous. Press Release
March, 2010 — Hemosphere, Inc., a private medical device company, has completed a late round of venture capital financing totaling $9.3 million. Kaiser Permanente Ventures, Oakland, Calif., is lead investor, and Mutual Capital Partners, Cleveland, is the second largest new … Continue reading
March 2010 — Kaiser Permanente Ventures, the media-shy VC arm of Oakland-based Kasier Permanente, was the lead investor in a $9.3 million financing round announced Wednesday by Hemosphere Inc., a private medical device company. See article here
March 2010 — Hemosphere, Inc., has raised more than $9.3 million in equity for its vascular access device that’s used by patients undergoing dialysis, according to a filing with the Securities and Exchange Commission. Read More
February 2010 — Drs. James Lin, George Nassar, and John Ross shared their clinical experiences at ASDIN in Orlando, FL in mid-February. Dr. Lin shared his experience referring a failing fistula to a HeRO access surgeon resulting in fistula salvage … Continue reading